Subtopic Deep Dive
Pulmonary Nanoparticles
Research Guide
What is Pulmonary Nanoparticles?
Pulmonary nanoparticles are engineered nanoscale particles (1-1000 nm) designed for inhalation delivery to target lung tissues, enabling deep penetration, controlled release, and evasion of mucociliary clearance.
Research covers synthesis via spray drying, aerosol stability, and biocompatibility for respiratory diseases (Vehring 2007, 1598 citations; Mansour et al. 2009, 466 citations). Over 50 papers from 2006-2019 address applications in COPD, asthma, and lung cancer therapy. Key methods include simulated biological fluids for testing (Marques et al. 2011, 1023 citations).
Why It Matters
Pulmonary nanoparticles improve drug efficacy for local lung diseases like cystic fibrosis by achieving alveolar deposition and sustained release (Mangal et al. 2017). They enable systemic delivery via transcytosis, bypassing first-pass metabolism for biologics (Ghadiri et al. 2019). de Jong (2008, 3763 citations) highlights toxicity risks balanced against therapeutic gains in respiratory applications; Kohane (2006) details size-dependent clearance evasion for chemotherapy (Mangal et al. 2017).
Key Research Challenges
Aerosol Stability
Nanoparticles aggregate in humid airstreams, reducing lung deposition (Vehring 2007). Spray drying controls morphology but requires optimization for inhalation (Vehring 2007, 1598 citations). Borghardt et al. (2018) note kinetic barriers in pulmonary transit.
Mucociliary Clearance
Particles under 500 nm face rapid clearance by cilia, limiting retention (Mansour et al. 2009). Surface modifications evade mucus but alter biocompatibility (de Jong 2008). Kohane (2006) reviews size effects on epithelial transcytosis.
Toxicity Assessment
Nanoscale effects trigger inflammation despite biocompatibility claims (de Jong 2008, 3763 citations). Simulated fluids test dissolution but miss dynamic lung conditions (Marques et al. 2011). Mangal et al. (2017) identify oxidative stress in cancer therapies.
Essential Papers
Drug delivery and nanoparticles: Applications and hazards
de Jong · 2008 · International Journal of Nanomedicine · 3.8K citations
Wim H De Jong1, Paul JA Borm2,31Laboratory for Toxicology, Pathology and Genetics, National Institute for Public Health and the Environment (RIVM), Bilthoven, The Netherlands; 2Zuyd University, Cen...
Pharmaceutical Particle Engineering via Spray Drying
Reinhard Vehring · 2007 · Pharmaceutical Research · 1.6K citations
Simulated Biological Fluids with Possible Application in Dissolution Testing
Margareth Marques, Raimar Löebenberg, May Almukainzi · 2011 · Dissolution Technologies · 1.0K citations
This literature review is a compilation of the composition and, in most cases, the preparation instructions for simulated biological fluids that may be used as dissolution media in the evaluation o...
Microparticles, Microspheres, and Microcapsules for Advanced Drug Delivery
Miléna Lengyel, Nikolett Kállai‐Szabó, Vince Antal et al. · 2019 · Scientia Pharmaceutica · 546 citations
Microparticles, microspheres, and microcapsules are widely used constituents of multiparticulate drug delivery systems, offering both therapeutic and technological advantages. Microparticles are ge...
Microparticles and nanoparticles for drug delivery
Daniel S. Kohane · 2006 · Biotechnology and Bioengineering · 497 citations
Abstract Particulate drug delivery systems have become important in experimental pharmaceutics and clinical medicine. The distinction is often made between micro‐ and nanoparticles, being particles...
Nanomedicine in pulmonary delivery
Heidi M. Mansour, Haemosu, Xiao Yu Wu · 2009 · International Journal of Nanomedicine · 466 citations
The lung is an attractive target for drug delivery due to noninvasive administration via inhalation aerosols, avoidance of first-pass metabolism, direct delivery to the site of action for the treat...
Inhaled Therapy in Respiratory Disease: The Complex Interplay of Pulmonary Kinetic Processes
Jens Markus Borghardt, Charlotte Kloft, Ashish Sharma · 2018 · Canadian Respiratory Journal · 290 citations
The inhalation route is frequently used to administer drugs for the management of respiratory diseases such as asthma or chronic obstructive pulmonary disease. Compared with other routes of adminis...
Reading Guide
Foundational Papers
Start with de Jong (2008, 3763 citations) for applications/hazards overview, Vehring (2007, 1598 citations) for spray drying engineering, and Mansour et al. (2009, 466 citations) for pulmonary specifics.
Recent Advances
Mangal et al. (2017, 278 citations) on lung cancer chemotherapy; Ghadiri et al. (2019, 265 citations) on absorption strategies; Lengyel et al. (2019, 546 citations) on micro/nano encapsulation.
Core Methods
Spray drying (Vehring 2007); simulated fluids testing (Marques et al. 2011); kinetic modeling (Borghardt et al. 2018).
How PapersFlow Helps You Research Pulmonary Nanoparticles
Discover & Search
Research Agent uses searchPapers('pulmonary nanoparticles inhalation') to retrieve 50+ papers like Mansour et al. (2009, 466 citations), then citationGraph reveals de Jong (2008) as top-cited foundational work with 3763 citations, and findSimilarPapers expands to spray drying methods (Vehring 2007). exaSearch uncovers niche aerosol stability studies.
Analyze & Verify
Analysis Agent applies readPaperContent on Mangal et al. (2017) to extract deposition data, verifies claims via verifyResponse (CoVe) against de Jong (2008) toxicity metrics, and runs PythonAnalysis with NumPy to model particle size distributions from Vehring (2007). GRADE grading scores evidence strength for biocompatibility claims.
Synthesize & Write
Synthesis Agent detects gaps in mucociliary evasion via gap detection across Kohane (2006) and Ghadiri et al. (2019), flags contradictions in stability data. Writing Agent uses latexEditText for methods sections, latexSyncCitations for 10+ references, latexCompile for full manuscripts, and exportMermaid diagrams particle kinetics.
Use Cases
"Analyze nanoparticle size effects on lung deposition from recent papers"
Research Agent → searchPapers → runPythonAnalysis (pandas plots size vs. deposition from Vehring 2007 data) → matplotlib output with statistical correlations.
"Draft LaTeX review on pulmonary nanoparticle toxicity"
Synthesis Agent → gap detection → Writing Agent → latexEditText (intro) → latexSyncCitations (de Jong 2008 et al.) → latexCompile → PDF with figures.
"Find GitHub code for spray drying simulations in inhalation nanoparticles"
Research Agent → paperExtractUrls (Vehring 2007) → paperFindGithubRepo → githubRepoInspect → Python simulation code for particle engineering.
Automated Workflows
Deep Research workflow conducts systematic review: searchPapers → citationGraph (de Jong cluster) → DeepScan 7-steps analyzes 20 papers with CoVe checkpoints on stability claims. Theorizer generates hypotheses on transcytosis from Mansour (2009) + Ghadiri (2019), outputting Mermaid flowcharts of evasion mechanisms.
Frequently Asked Questions
What defines pulmonary nanoparticles?
Particles 1-1000 nm engineered for inhalation, focusing on aerosol stability and lung targeting (Kohane 2006; Mansour et al. 2009).
What are key synthesis methods?
Spray drying for morphology control (Vehring 2007, 1598 citations); microencapsulation for controlled release (Lengyel et al. 2019).
What are major papers?
de Jong (2008, 3763 citations) on applications/hazards; Mansour et al. (2009, 466 citations) on pulmonary nanomedicine; Mangal et al. (2017) on cancer delivery.
What open problems exist?
Toxicity in chronic dosing (de Jong 2008); clearance evasion for biologics (Ghadiri et al. 2019); scale-up from lab to inhalers (Borghardt et al. 2018).
Research Inhalation and Respiratory Drug Delivery with AI
PapersFlow provides specialized AI tools for Medicine researchers. Here are the most relevant for this topic:
Systematic Review
AI-powered evidence synthesis with documented search strategies
AI Literature Review
Automate paper discovery and synthesis across 474M+ papers
Find Disagreement
Discover conflicting findings and counter-evidence
Paper Summarizer
Get structured summaries of any paper in seconds
See how researchers in Health & Medicine use PapersFlow
Field-specific workflows, example queries, and use cases.
Start Researching Pulmonary Nanoparticles with AI
Search 474M+ papers, run AI-powered literature reviews, and write with integrated citations — all in one workspace.
See how PapersFlow works for Medicine researchers